MEDICAL DEVICE CLINICAL TRIALS

Medical Device News Magazine brings healthcare professionals, researchers, medical device executives, investors, and industry leaders timely coverage of the latest medical device clinical trials, clinical research studies, emerging scientific data, and technological developments shaping the future of medicine and healthcare.

Our coverage follows medical technologies throughout the clinical development process—from early feasibility and first-in-human studies to pivotal clinical trials, long-term follow-up studies, post-market research, and real-world evidence. Readers can stay informed about new devices and technologies being evaluated across a broad range of medical specialties, including cardiovascular care, vascular medicine, orthopedics, surgery, medical imaging, diagnostics, oncology, neurology, digital health, robotic-assisted surgery, and other rapidly evolving areas of healthcare.

Medical Device News Magazine also reports on important clinical trial results and regulatory milestones, including significant study endpoints, patient outcomes, safety and efficacy findings, FDA submissions, approvals and clearances, and other developments that may influence the commercialization and adoption of new medical technologies.

Beyond reporting study results, our coverage examines the broader significance of medical device research. We highlight innovations that have the potential to improve patient outcomes, provide physicians with new treatment options, reduce procedural complexity, advance minimally invasive care, improve diagnostic accuracy, and address unmet clinical needs.

As medical technology continues to advance at an extraordinary pace, clinical evidence has become increasingly important to physicians, healthcare organizations, regulators, manufacturers, investors, and other decision-makers. Understanding the research behind emerging technologies can provide valuable insight into which innovations may ultimately influence clinical practice and reshape standards of care.

With comprehensive reporting, industry perspectives, and coverage of important scientific and regulatory developments, Medical Device News Magazine helps readers understand not only what is happening in medical device clinical research, but also why it matters.

Whether you are a physician evaluating emerging treatment options, a researcher following new clinical evidence, a medical device executive monitoring industry developments, or an investor assessing the next generation of healthcare technologies, Medical Device News Magazine provides the timely information and insights you need to stay informed in an increasingly innovative and rapidly evolving industry.

Innovent Biologics Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer and Other Solid Tumors at the 2024 ESMO Virtual Plenary

Dr. Hui Zhou, Senior Vice President of Innovent, stated: “IBI363, as a first-in-class molecule, represents Innovent’s continuous innovation and advancement in the immunotherapy field. Starting from molecular design, the unique approach of α bias with β and γ attenuated were creatively adopted, which greatly improved the therapeutic window of IL-2. Meanwhile, through the specific traction of PD-1, tumor-specific T cells expressing both PD-1 and CD25 can be selectively stimulated and amplified, thus exerting anti-tumor effects. IBI363 has demonstrated excellent druggability with antibody-like pharmacokinetics (IgG-like PK) and low immunogenicity.